# Defining tau PET positivity grey zones for MK6240 and Flortaucipir quantification

**Authors:** Guilherme Povala, Bruna Bellaver, Guilherme Bauer‐Negrini, Emma Ruppert, Marina Scop Medeiros, Livia Amaral, Firoza Z Lussier, Pamela C.L. Ferreira, Carolina Soares, Dana L Tudorascu, Quentin Finn, Joseph C. Masdeu, Hwamee Oh, Juan Fortea, David N. Soleimani‐Meigooni, Val J Lowe, Brian A. Gordon, Belen Pascual, Pedro Rosa‐Neto, Suzanne L. Baker, Tharick A Pascoal

PMC · DOI: 10.1002/alz70856_106847 · Alzheimer's & Dementia · 2026-01-08

## TL;DR

This study defines 'gray zones' for tau PET thresholds using two tracers, showing how confidence in tau positivity changes across a continuous scale.

## Contribution

Introduces a standardized method using Uniτ to define tau PET positivity gray zones across different tracers.

## Key findings

- Uniτ gray zones showed consistent thresholds between MK6240 and Flortaucipir tracers.
- Higher TVR+ probabilities corresponded to increased Uniτ values for both tracers.
- More participants fell into the gray zone for Flortaucipir compared to MK6240.

## Abstract

Tau PET measures are inherently continuous and applying dichotomized thresholds introduces conceptual and analytical idiosyncrasies. Understanding the limitations in the transition from tau‐negative to tau‐positive classifications is crucial for the effective use of these thresholds. This study aims to determine the confidence levels of tau PET thresholds of abnormality for different tau PET tracers by characterizing their “gray zone” using the universal tau PET scale (Uniτ, www.unitau.app).

We evaluated 485 individuals across the aging and AD spectrum from the HEAD study, with head‐to‐head scans for MK6240 and Flortaucipir. Uniτ estimates were derived from the Meta‐Temporal ROI. Tau positivity (T+) was defined as Uniτ values exceeding the mean plus 3 SD of individuals younger than 28 years (n = 24). Two physicians independently performed a visual assessment of tau positivity for each tracer, with agreement indicating clear tau pathology (TVR+). Logistic regression was used to estimate the probability of TVR+ across Uniτ values for each tracer (n = 189, CU elderly Aβ‐ and CI Aβ+). Individuals were classified as negative, positive, or within a “gray zone” between the most liberal T+ threshold and varying TVR+ probability thresholds (50%, 75%, 90%, 95%, and 99%).

The Uniτ gray zone, defined as a function of TVR+ probabilities, demonstrated consistency between the two tracers, with differences observed only in the decimal range. The most liberal Uniτ threshold for T+ was 11.0 for both MK6240 and Flortaucipir, closely matching the 50% TVR+ probability threshold (11.1 for MK6240 and 11.7 for Flortaucipir). Higher TVR+ probabilities corresponded to increased Uniτ values with MK6240 and Flortaucipir showing near‐identical values between the tracers: 14.2 and 14.8 for 75%, 17.3 and 17.9 for 90%, 19.4 and 19.9 for 95%, and 24.1 and 24.6 for 99%, respectively (Figure 1). In total, 26 participants fell within the gray zone for MK6240, compared to 47 participants for Flortaucipir.

These findings highlight the potential of Uniτ to provide a standardized approach for assessing tau positivity across tracers. By combining quantitative Uniτ measures with visual assessments, we enhance the understanding of tau positivity certainty, particularly in the transition between negative and positive classifications.

## Linked entities

- **Chemicals:** MK6240 (PubChem CID 118577045), Flortaucipir (PubChem CID 71059746)
- **Diseases:** Alzheimer's disease (MONDO:0004975)

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12782314/full.md

---
Source: https://tomesphere.com/paper/PMC12782314